Skip to content
Technology Opportunities & Ventures
While focus is on header menu items,
press the down arrow to open sub-menu.

For Innovators

Getting your innovations out into the world and to the people that need them.

In This Section

‹ Home › Startups › Our Startup Portfolio › Ajax Therapeutics

Startups

Ajax Therapeutics

Ajax Therapeutics

2019
Active

Principal Investigators: Stevan Hubbard, PhD

Ajax Therapeutics is a biotech company that develops precision therapies for blood cancers called myeloproliferative neoplasms (MPNs). They use computational chemistry and structural biology to create highly selective therapies that target specific proteins involved in the development of MPNs. Ajax aims to improve treatment efficacy and reduce side effects for MPN patients.